Richard S. Blumberg

Richard S. Blumberg

Founder at Syntimmune, Inc.

Consumer Services
Health Technology
Commercial Services

Profile

Richard S.
Blumberg
is the founder of Bioverativ Therapeutics, Inc. (founded in 1999) and Syntimmune, Inc. (founded in 2013).
He is currently a Professor at Harvard University, a Member of the Association of American Physicians, and a Member of the American Society of Clinical Investigation.
His former positions include Chairman of Crohn's & Colitis Foundation of America and Member of the National Institutes of Health.
Blumberg's education includes an undergraduate degree from Carnegie Mellon University, a doctorate from Thomas Jefferson University, a graduate degree from Harvard University, and an MBA from Northeastern University.

Richard S. Blumberg active positions

CompaniesPositionStart
Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal -
Corporate Officer/Principal -
Founder 2012-12-31
All active positions of Richard S. Blumberg

Former positions of Richard S. Blumberg

CompaniesPositionEnd
Chairman -
Corporate Officer/Principal -
Founder -
See the detail of Richard S. Blumberg's experience

Training of Richard S. Blumberg

Carnegie Mellon University Undergraduate Degree
Harvard University Graduate Degree
Thomas Jefferson University Doctorate Degree
Northeastern University Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard S. Blumberg's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies6

Health Technology

Commercial Services

Government

American Society of Clinical Investigation

Commercial Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Richard S. Blumberg